Literature DB >> 20601290

How B cells influence bone biology in health and disease.

Mark C Horowitz1, Jackie A Fretz, Joseph A Lorenzo.   

Abstract

It is now well established that important regulatory interactions occur between the cells in the hematopoietic, immune and skeletal systems (osteoimmunology). B lymphocytes (B cells) are responsible for the generation and production of antibodies or immunoglobulins in the body. Together with T cells these lymphocytes comprise the adaptive immune system, which allows an individual to develop specific responses to an infection and retain memory of that infection, allowing for a faster and more robust response if that same infection occurs again. In addition to this immune function, B cells have a close and multifaceted relationship with bone cells. B cells differentiate from hematopoietic stem cells (HSCs) in supportive niches found on endosteal bone surfaces. Cells in the osteoblast lineage support HSC and B cell differentiation in these niches. B cell differentiation is regulated, at least in part, by a series of transcription factors that function in a temporal manner. While these transcription factors are required for B cell differentiation, their loss causes profound changes in the bone phenotype. This is due, in part, to the close relationship between macrophage/osteoclast and B cell differentiation. Cross talk between B cells and bone cells is reciprocal with defects in the RANKL-RANK, OPG signaling axis resulting in altered bone phenotypes. While the role of B cells during normal bone remodeling appears minimal, activated B cells play an important role in many inflammatory diseases with associated bony changes. This review examines the relationship between B cells and bone cells and how that relationship affects the skeleton and hematopoiesis during health and disease. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601290      PMCID: PMC2941392          DOI: 10.1016/j.bone.2010.06.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  78 in total

Review 1.  Biology of hematopoietic stem cells and progenitors: implications for clinical application.

Authors:  Motonari Kondo; Amy J Wagers; Markus G Manz; Susan S Prohaska; David C Scherer; Georg F Beilhack; Judith A Shizuru; Irving L Weissman
Journal:  Annu Rev Immunol       Date:  2002-12-17       Impact factor: 28.527

2.  Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

Authors:  Guitty Eghbali-Fatourechi; Sundeep Khosla; Arunik Sanyal; William J Boyle; David L Lacey; B Lawrence Riggs
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Assembling a gene regulatory network for specification of the B cell fate.

Authors:  Kay L Medina; Jagan M R Pongubala; Karen L Reddy; David W Lancki; Rodney Dekoter; Matthias Kieslinger; Rudolf Grosschedl; Harinder Singh
Journal:  Dev Cell       Date:  2004-10       Impact factor: 12.270

4.  Stimulation of B-cell progenitors by cloned murine interleukin-7.

Authors:  A E Namen; S Lupton; K Hjerrild; J Wignall; D Y Mochizuki; A Schmierer; B Mosley; C J March; D Urdal; S Gillis
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

5.  Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.

Authors:  Sun-Kyeong Lee; Judith F Kalinowski; Sandra L Jastrzebski; Lynn Puddington; Joseph A Lorenzo
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

6.  Regulation of E2A gene expression in B-lymphocyte development.

Authors:  Yuan Zhuang; Annette Jackson; Lihua Pan; Kang Shen; Meifang Dai
Journal:  Mol Immunol       Date:  2004-03       Impact factor: 4.407

7.  Hematopoiesis is severely altered in mice with an induced osteoblast deficiency.

Authors:  Dora Visnjic; Zana Kalajzic; David W Rowe; Vedran Katavic; Joseph Lorenzo; Hector L Aguila
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

8.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

9.  Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice.

Authors:  Claudine Blin-Wakkach; Abdelilah Wakkach; Nathalie Rochet; Georges F Carle
Journal:  J Bone Miner Res       Date:  2004-03-22       Impact factor: 6.741

10.  The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors.

Authors:  Vedran Katavić; Danka Grcević; Sun Kyeong Lee; Judith Kalinowski; Sandra Jastrzebski; William Dougall; Dirk Anderson; Lynn Puddington; H Leonardo Aguila; Joseph A Lorenzo
Journal:  Bone       Date:  2003-06       Impact factor: 4.398

View more
  37 in total

1.  Absence of sclerostin adversely affects B-cell survival.

Authors:  Corey J Cain; Randell Rueda; Bryce McLelland; Nicole M Collette; Gabriela G Loots; Jennifer O Manilay
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

2.  Impaired ATM activation in B cells is associated with bone resorption in rheumatoid arthritis.

Authors:  Kofi A Mensah; Jeff W Chen; Jean-Nicolas Schickel; Isabelle Isnardi; Natsuko Yamakawa; Andrea Vega-Loza; Jennifer H Anolik; Richard A Gatti; Erwin W Gelfand; Ruth R Montgomery; Mark C Horowitz; Joe E Craft; Eric Meffre
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

3.  Acute exposure to high dose γ-radiation results in transient activation of bone lining cells.

Authors:  Russell T Turner; Urszula T Iwaniec; Carmen P Wong; Laurence B Lindenmaier; Lindsay A Wagner; Adam J Branscum; Scott A Menn; James Taylor; Ye Zhang; Honglu Wu; Jean D Sibonga
Journal:  Bone       Date:  2013-08-14       Impact factor: 4.398

4.  Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss.

Authors:  Melda Onal; Jinhu Xiong; Xinrong Chen; Jeff D Thostenson; Maria Almeida; Stavros C Manolagas; Charles A O'Brien
Journal:  J Biol Chem       Date:  2012-07-10       Impact factor: 5.157

Review 5.  Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

Authors:  Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

6.  Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice.

Authors:  Hector L Aguila; Se Hwan Mun; Judith Kalinowski; Douglas J Adams; Joseph A Lorenzo; Sun-Kyeong Lee
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 7.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

8.  Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.

Authors:  Jungeun Yu; Stefano Zanotti; Lauren Schilling; Chris Schoenherr; Aris N Economides; Archana Sanjay; Ernesto Canalis
Journal:  Am J Pathol       Date:  2018-03-12       Impact factor: 4.307

9.  Immunology of Gut-Bone Signaling.

Authors:  Fraser L Collins; Jonathan D Schepper; Naiomy Deliz Rios-Arce; Michael D Steury; Ho Jun Kang; Heather Mallin; Daniel Schoenherr; Glen Camfield; Saima Chishti; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 10.  Treatment of post-menopausal osteoporosis: beyond bisphosphonates.

Authors:  S Ishtiaq; I Fogelman; G Hampson
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.